Skip to content

Prospective feasibility pilot study evaluating the value of [68Ga]Ga-PENTIXAFOR PET-CT in patients with metastatic Small Cell Lung Cancer (SCLC) at diagnosis and disease progression (PASSIFLORE)

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-514057-30-00
Acronym
ICO-2023-16
Enrollment
15
Registered
2025-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cell lung carcinoma

Interventions

None listed

Sponsors

Institut De Cancerologie De L Ouest
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026